Curaleaf Holdings (CURLF) Total Liabilities (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Total Liabilities of $2.0 billion for Q4 2025, up 2.49% year-over-year from $2.0 billion in Q4 2024, and up 2.49% quarter-over-quarter from $2.0 billion in Q4 2024.
Curaleaf Holdings (CURLF) Total Liabilities (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Total Liabilities history runs 7 years deep, the most recent figure standing at $2.0 billion for Q4 2025.
- In Q4 2025, Total Liabilities rose 2.49% year-over-year to $2.0 billion; the TTM figure through Dec 2025 stood at $2.0 billion (up 2.49% YoY), while the FY2025 annual figure was $2.0 billion, up 2.49% from the prior year.
- Total Liabilities for Q4 2025 stood at $2.0 billion, up from $2.0 billion in the prior quarter.
- The five-year high for Total Liabilities was $2.0 billion in Q3 2023, with the low at $1.7 million in Q1 2022.
- The 5-year median for Total Liabilities is $1.9 billion (2022), against an average of $1.6 billion.
- The sharpest annual moves came in 2021 and 2022: Total Liabilities surged 46.23% in 2021, then tumbled 99.84% in 2022.
- Curaleaf Holdings' Total Liabilities stood at $1.4 billion in 2021, then gained by 27.69% to $1.8 billion in 2022, then increased by 4.71% to $1.9 billion in 2023, then grew by 1.61% to $2.0 billion in 2024, then climbed by 2.49% to $2.0 billion in 2025.
- Business Quant data shows CURLF's Total Liabilities at $2.0 billion in Q4 2025, $2.0 billion in Q4 2024, and $2.0 billion in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 1.95 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Bn |
| Dec 31, 2025 | 2.01 Bn |
| Dec 31, 2024 | 1.96 Bn |
| Sep 30, 2024 | 1.99 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Dec 31, 2023 | 1.93 Bn |
| Sep 30, 2023 | 2.01 Bn |
| Jun 30, 2023 | 2.00 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.74 Bn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.44 Bn |
| Sep 30, 2021 | 1.41 Bn |
| Jun 30, 2021 | 1.35 Bn |
| Mar 31, 2021 | 1.08 Bn |
| Dec 31, 2020 | 984.72 Mn |
| Sep 30, 2020 | 973.59 Mn |
| Dec 31, 2019 | 333.48 Mn |